XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency 
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022
EUROAPI listing on Euronext Paris expected on May 6, 2022 French AMF approved EUROAPI’s listing prospectus EUROAPI first day of...
Perimeter Medical Imaging AI Announces Its Participation in Multiple Upcoming Investor Conferences
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven...
CONMED Corporation to Announce First Quarter 2022 Financial Results on April 27, 2022
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after...
6 Dosell are Implemented in a New Municipality
STOCKHOLM, SWEDEN / ACCESSWIRE / April 1, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Careium...
Love Hemp Group PLC Announces Response to the Latest FSA Novel Foods Update
LONDON, UK / ACCESSWIRE / April 1, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed...
Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER METASTASISWorld-class research...
Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled ‘Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis’
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
Spexis Publishes Invitation to Annual General Meeting 2022
Ad hoc announcement pursuant to Art. 53 LR- Pre-AGM information call on April 7, 2022 at 2:30PM CET- AGM to...
Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
XPhyto Closes First Tranche of Financing
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis
San Diego, California--(Newsfile Corp. - March 31, 2022) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company specializing in the...
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™...
Global Launch of New Ultra-Portable Fundus Camera, from epipole, at Vision Expo East (NYC)
epiCam: the power of desktop retinal imaging, in the palm of your hand NEW YORK, March 31, 2022 /PRNewswire/ -- epipole,...
Orbita Welcomes New Heads of Sales and Marketing
Sarah Inman and Elizabeth Glaser join Orbita BOSTON, March 31, 2022 /PRNewswire/ -- Orbita, the leading provider of secure voice and...
Reema Health Secures $8 Million in Seed Funding Round
Investments in breakthrough community-based health technology platform top $10 million to date MINNEAPOLIS, March 31, 2022 /PRNewswire-PRWeb/ --Reema Health, a...
SmartTab CMO Honored in NYC at the MM+M Magazine 40 Under 40 Gala
Sacha was the only honoree from a Colorado-based company. NEW YORK, March 31, 2022 /PRNewswire/ -- MM+M awarded its newest...
US Real World Evidence Solution Industry to 2027 – Featuring IBM, IQVIA and SAS Institute Among Others
DUBLIN, March 31, 2022 /PRNewswire/ -- The "Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by...
CathWorks Presents New Data and Latest Innovations at ACC 2022
CathWorks FFRangio™ System outcomes study to be presented at ACC 2022 CathWorks announces the completion of more than 5,000 FFRangio cases...
Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Named Finalist for MD+DI Medical Design Excellence Award
INCLINE VILLAGE, Nev., March 31, 2022 /PRNewswire/ -- Kleiner Device Labs today announced that its new KG2TM SurgeTM flow-thru interbody...
OM1 LAUNCHES NEW MENTAL HEALTH AND NEUROSCIENCE REAL-WORLD DATA NETWORK
Dr. Carl D. Marci joins OM1 to lead specialty area focused on major depression, schizophrenia, multiple sclerosis, and more BOSTON,...